Lifestyle Exposures and Eye Diseases in Adults

American Journal of Ophthalmology

Volumn 144, Issue 6, 2007, Pages

  Klein, Barbara E K ^a   Klein, Ronald ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CAROTENE; CAROTENOID; DOCOSAHEXAENOIC ACID; GINKGO BILOBA EXTRACT; GLUTATHIONE; GRAPE SEED EXTRACT; ICOSAPENTAENOIC ACID; LIGNAN; MULTIVITAMIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; PLANT EXTRACT; RETINOL; RIBOFLAVIN; THIAMINE; UNCLASSIFIED DRUG; VITAMIN B COMPLEX; XANTHOPHYLL; ZEAXANTHIN; ZINC;

ADULT; ADULTHOOD; ALCOHOL CONSUMPTION; ARTICLE; BEHAVIOR MODIFICATION; CATARACT; CLIMATE; DATA ANALYSIS; DIABETIC RETINOPATHY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG MEGADOSE; DRY EYE; EYE DISEASE; EYE INJURY; EYE PROTECTION; HUMAN; LIFESTYLE; LIGHT EXPOSURE; OCCUPATIONAL EXPOSURE; OPEN ANGLE GLAUCOMA; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RECREATION; REFRACTION ERROR; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; RISK REDUCTION; SMOKING;

EID: 36249028257     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.08.016     Document Type: Article

References (69)

1. Hill A.B. The environment and disease: association or causation?. Proc R Soc Med 58 (1965) 295-300
2. Kelly S.P., Thornton J., Edwards R., et al. Smoking and cataract: review of causal association. J Cataract Refract Surg 31 (2005) 2395-2404
3. Klein B.E., Klein R., Linton K.L., et al. Cigarette smoking and lens opacities: the Beaver Dam Eye Study. Am J Prev Med 9 (1993) 27-30
4. Christen W.G., Glynn R.J., Ajani U.A., et al. Smoking cessation and risk of age-related cataract in men. JAMA 284 (2000) 713-716
5. Hiratsuka Y., and Li G. Alcohol and eye diseases: a review of epidemiologic studies. J Stud Alcohol 62 (2001) 397-402
6. Ritter L.L., Klein B.E., Klein R., et al. Alcohol use and lens opacities in the Beaver Dam Eye Study. Arch Ophthalmol 111 (1993) 113-117
7. Jacques P.F., Taylor A., Moeller S., et al. Long-term nutrient intake and 5-year change in nuclear lens opacities. Arch Ophthalmol 123 (2005) 517-526
8. Taylor A., Jacques P.F., Chylack Jr. L.T., et al. Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities. Am J Clin Nutr 75 (2002) 540-549
9. Cumming R.G., Mitchell P., and Smith W. Diet and cataract: the Blue Mountains Eye Study. Ophthalmology 107 (2000) 450-456
10. Mares-Perlman J.A., Klein B.E., Klein R., et al. Relation between lens opacities and vitamin and mineral supplement use. Ophthalmology 101 (1994) 315-325
11. Sperduto R.D., Hu T.S., Milton R.C., et al. The Linxian cataract studies. Two nutrition intervention trials. Arch Ophthalmol 111 (1993) 1246-1253
12. Chylack Jr. L.T., Brown N.P., Bron A., et al. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol 9 (2002) 49-80
13. Gritz D.C., Srinivasan M., Smith S.D., et al. The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India. Br J Ophthalmol 90 (2006) 847-851
14. McNeil J.J., Robman L., Tikellis G., et al. Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology 111 (2004) 75-84
15. The Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report no. 8. Arch Ophthalmol 119 (2001) 1417-1436
16. Milton R.C., Sperduto R.D., Clemons T.E., et al. Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study: a propensity score approach. AREDS Report no. 21. Ophthalmology 113 (2006) 1264-1270
17. Bjelakovic G., Nikolova D., Gluud L.L., et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297 (2007) 842-857
18. Bast A., and Haenen G.R. The toxicity of antioxidants and their metabolites. Environ Toxicol Pharmacol 11 (2002) 251-258
19. Asbell P.A., Dualan I., Mindel J., et al. Age-related cataract. Lancet 365 (2005) 599-609
20. Taylor H.R., West S.K., Rosenthal F.S., et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med 319 (1988) 1429-1433
21. Cruickshanks K.J., Klein B.E., and Klein R. Ultraviolet light exposure and lens opacities: the Beaver Dam Eye Study. Am J Public Health 82 (1992) 1658-1662
22. West S.K., Longstreth J.D., Munoz B.E., et al. Model of risk of cortical cataract in the US population with exposure to increased ultraviolet radiation due to stratospheric ozone depletion. Am J Epidemiol 162 (2005) 1080-1088
23. Thornton J., Edwards R., Mitchell P., et al. Smoking and age-related macular degeneration: a review of association. Eye 19 (2005) 935-944
24. Chakravarthy U., Augood C., Bentham G.C., et al. Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology 114 (2007) 1157-1163
25. Mitchell P., Chapman S., and Smith W. "Smoking is a major cause of blindness.". Med J Aust 171 (1999) 173-174
26. Scholl H.P., Fleckenstein M., Charbel I.P., et al. An update on the genetics of age-related macular degeneration. Mol Vis 13 (2007) 196-205
27. Schaumberg D.A., Hankinson S.E., Guo Q., et al. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol 125 (2007) 55-62
28. Seddon J.M., Francis P.J., George S., et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 297 (2007) 1793-1800
29. Ritter L.L., Klein R., Klein B.E., et al. Alcohol use and age-related maculopathy in the Beaver Dam Eye Study. Am J Ophthalmol 120 (1995) 190-196
30. Fraser-Bell S., Wu J., Klein R., et al. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study. Am J Ophthalmol 141 (2006) 79-87
31. Smith W., and Mitchell P. Alcohol intake and age-related maculopathy. Am J Ophthalmol 122 (1996) 743-745
32. Moss S.E., Klein R., Klein B.E., et al. Alcohol consumption and the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 105 (1998) 789-794
33. Arnarsson A., Sverrisson T., Stefansson E., et al. Risk factors for 5-year incident age-related macular degeneration: the Reykjavik Eye Study. Am J Ophthalmol 142 (2006) 419-428
34. Klein R., Klein B.E., Tomany S.C., et al. Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol 156 (2002) 589-598
35. Obisesan T.O., Hirsch R., Kosoko O., et al. Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1. J Am Geriatr Soc 46 (1998) 1-7
36. Mozaffarieh M., Sacu S., and Wedrich A. The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence. Nutr J 2 (2003) 20
37. Hogg R., and Chakravarthy U. AMD and micronutrient antioxidants. Curr Eye Res 29 (2004) 387-401
38. Mares-Perlman J.A., Brady W.E., Klein R., et al. Dietary fat and age-related maculopathy. Arch Ophthalmol 113 (1995) 743-748
39. Taylor H.R., Tikellis G., Robman L.D., et al. Vitamin E supplementation and macular degeneration: randomized controlled trial. BMJ 325 (2002) 11
40. Rein D.B., Saaddine J.B., Wittenborn J.S., et al. Cost-effectiveness of vitamin therapy for age-related macular degeneration. Ophthalmology 114 (2007) 1319-1326
41. Evans J.R. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev (2006) CD000254
42. Hodge W.G., Schachter H.M., Barnes D., et al. Efficacy of omega-3 fatty acids in preventing age-related macular degeneration: a systematic review. Ophthalmology 113 (2006) 1165-1172
43. Klein R., Moss S.E., Klein B.E., et al. Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 149 (1989) 266-272
44. Valmadrid C.T., Klein R., Moss S.E., et al. Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus. JAMA 282 (1999) 239-246
45. Millen A.E., Gruber M., Klein R., et al. Relations of serum ascorbic acid and alpha-tocopherol to diabetic retinopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 158 (2003) 225-233
46. Mayer-Davis E.J., Bell R.A., Reboussin B.A., et al. Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. Ophthalmology 105 (1998) 2264-2270
47. Millen A.E., Klein R., Folsom A.R., et al. Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 79 (2004) 865-873
48. LaPorte R.E., Dorman J.S., Tajima N., et al. Pittsburgh Insulin-Dependent Diabetes Mellitus Morbidity and Mortality Study: physical activity and diabetic complications. Pediatrics 78 (1986) 1027-1033
49. Cruickshanks K.J., Moss S.E., Klein R., et al. Physical activity and proliferative retinopathy in people diagnosed with diabetes before age 30. Diabetes Care 15 (1992) 1267-1272
50. Kang J.H., Pasquale L.R., Willett W., et al. Antioxidant intake and primary open-angle glaucoma: a prospective study. Am J Epidemiol 158 (2003) 337-346
51. Quigley H.A., West S.K., Rodriguez J., et al. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol 119 (2001) 1819-1826
52. Bonovas S., Filioussi K., Tsantes A., et al. Epidemiological association between cigarette smoking and primary open-angle glaucoma: a meta-analysis. Public Health 118 (2004) 256-261
53. Kang J.H., Willett W.C., Rosner B.A., et al. Prospective study of alcohol consumption and the risk of primary open-angle glaucoma. Ophthalmic Epidemiol 14 (2007) 141-147
54. Fan B.J., Leung Y.F., Wang N., et al. Genetic and environmental risk factors for primary open-angle glaucoma. Chin Med J (Engl) 117 (2004) 706-710
55. Peczon J.D., and Grant W.M. Glaucoma, alcohol and intraocular pressure. Arch Ophthalmol 73 (1965) 495-500
56. Houle R.E., and Grant W.M. Alcohol, vasopressin, and intraocular pressure. Invest Ophthalmol Vis Sci 6 (1967) 145-154
57. Kang J.H., Pasquale L.R., Willett W.C., et al. Dietary fat consumption and primary open-angle glaucoma. Am J Clin Nutr 79 (2004) 755-764
58. Stewart W.C., Sine C., Sutherland S., et al. Total cholesterol and high-density lipoprotein levels as risk factors for increased intraocular pressure. Am J Ophthalmol 122 (1996) 575-577
59. Ritch R. Complementary therapy for the treatment of glaucoma: a perspective. Ophthalmol Clin North Am 18 (2005) 597-609
60. Qureshi I.A. The effects of mild, moderate, and severe exercise on intraocular pressure in glaucoma patients. Jpn J Physiol 45 (1995) 561-569
61. Shapiro A., Wolf E., Ferber I., et al. The effect of physical activity on the intraocular pressure of glaucomatous patients. Eur J Appl Physiol Occup Physiol 52 (1983) 136-138
62. Wong T.Y., Klein B.E., and Klein R. The prevalence and 5-year incidence of ocular trauma: the Beaver Dam Eye Study. Ophthalmology 107 (2000) 2196-2202
63. Moss S.E., Klein R., and Klein B.E.K. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 118 (2000) 1264-1268
64. Moss S.E., Klein R., and Klein B.E.K. Incidence of dry eye in an older population. Arch Ophthalmol 122 (2004) 369-373
65. Miljanovic B., Trivedi K.A., Dana M.R., et al. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr 82 (2005) 887-893
66. Saw S.M., Katz J., Schein O.D., Chew S.J., and Chan T.K. Epidemiology of myopia. Epidemiol Rev 18 (1996) 175-187
67. Firth A.Y. Editorial: ocular effects of criminal drug use. Can J Ophthalmol 41 (2006) 140-146
68. McLane N.J., and Carroll D.M. Ocular manifestations of drug abuse. Surv Ophthalmol 30 (1986) 298-313
69. Firth A.Y. Ocular sequelae from the illicit use of class A drugs. Br Ir Orthopt J 1 (2004) 10-18